Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary

Qiangjun Cai1, Kimberly A Skelding, Arthur T Armstrong

  • 1Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA.

Insights

Predictors of creatine kinase-MB (CK-MB) increase after percutaneous coronary intervention (PCI) were identified. Chest pain at the procedure

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Biomarkers

Background:

  • Limited data exist on predictors of periprocedural creatine kinase-MB (CK-MB) increase post-elective percutaneous coronary intervention (PCI) in the stenting era.
  • Understanding these predictors is crucial for risk stratification and patient management.

Purpose of the Study:

  • To explore the predictors of periprocedural CK-MB increase following elective PCI.
  • To identify factors associated with minor and major CK-MB elevations after PCI.

Main Methods:

  • Retrospective analysis of 882 patients with normal preprocedural CK-MB undergoing 919 elective PCIs.
  • Patients categorized into normal, minor (1-3x normal), and major (>3x normal) peak CK-MB groups.
  • Logistic regression analysis to identify independent predictors for CK-MB increase.

Main Results:

  • Independent predictors for minor CK-MB increase included thrombus, number of lesions, balloon size, type C lesion, chest pain during procedure, dissection, and side branch occlusion.
  • Independent predictors for major CK-MB increase included chest pain at end of procedure, type C lesion, severe angina, thrombus, and abrupt closure.
  • Chest pain at the end of the procedure was the strongest predictor for major CK-MB increase.

Conclusions:

  • Baseline clinical and angiographic characteristics, along with procedural complications, are associated with periprocedural CK-MB increases after PCI.
  • Patients experiencing chest pain at the end of the procedure face the highest risk of major CK-MB elevation.
  • These findings aid in identifying high-risk patients and optimizing PCI strategies.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...